Main Menu

Clinical Academic Radiotherapy Team (Dearnaley)

Professor David Dearnaley’s team was researching ways to better target a tumour during radiotherapy while avoiding healthy tissue around it. Professor Dearnaley retired in August 2020.

Team leader

Professor David Dearnaley

Professor David Dearnaley

Professor David Dearnaley has been central to the development of intensity modulated radiotherapy – a new radiotherapy technique that reduces damage to healthy tissue. He ran several trials for treating prostate cancer and investigated new image-guided radiotherapy techniques. Professor Dearnaley retired in August 2020.

ORCID 0000-0002-3954-2806

Team members

Dr Sarah Gulliford

Staff Scientist